Hyloris Pharmaceuticals’ Post

In this insightful article are summarized the key strategic considerations around the commercial and operational steps to undertake for first-time launchers. Enjoy the read!

Thoughts on this? >> Mid-week links >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #healthcare #productmarketing

Thoughts on this? >> Mid-week links >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #healthcare #productmarketing

Ladies and gentlemen, grab your popcorn and settle in for the most amazing event in the biopharma world! The Efficiency Olympics are here, and small and medium biopharma companies are competing in the ultimate game of saving money and optimizing operations. Who will take home the gold? Watch as our fearless teams: 🧭Navigate the Obstacle Course of Budgeting: It’s a wild ride through spreadsheets and receipts! Will they avoid the pitfall of going with a huge company that does clinical trials AND advertising and a whole bunch of other stuff? Stay tuned! 🏃♀️Sprint Through the Efficiency Challenges: Think you can avoid the pitfalls of endless revisions? No product team will win gold if they revise their core vis-aid 48 times. 😳Leap Over the Hurdles of Never Ending Billable Hours: This is where the competition can get tough for our teams - if they choose a giant ad agency, they are not likely to make it to the medal round. This isn’t just a competition—it’s a showcase of innovation, determination, and the relentless pursuit of excellence. Every dollar counts and every second saved could mean life-saving medicines reaching the market faster, helping patients who need them most. 🏆Join us for a front-row seat to the competition, where the product team that figures out small, expert teams will save them tons of money and help them win the competition! Are you ready to see who wins the gold in innovation and efficiency and finding the right fit for their needs and budget? Let the games begin! Stay tuned for updates, highlights, and interviews with our star competitors. Let’s cheer on these incredible teams as they strive for greatness (and have a few laughs) in the Efficiency Olympics! 🥇Now who wants to find out how the 1.11 Group can help your product become a gold medalist? What have you done to realize efficiencies in YOUR business? Leave me a comment below! www.111-group.com/pharma #biopharma #marketing #biotechceosisterhood

Biotechs making their commercial debut can improve their launch success rate and overall financial performance by learning from successful first-time launchers.

🚀 Exciting News! We’re Thrilled to Announce Our New Partnership with Aurobindo Pharma USA, Inc.! 🚀 We’re proud to partner with Aurobindo to bring their employees exclusive savings through Previ! 🎉 Here’s the deal: Previ empowers employees to save $1,200+ per year on essential services like T-Mobile and AT&T cell phone service— while providing them premium and unlimited plans. Better plans and less 💸. 👉 What’s in it for Aurobindo USA? ✔️ $0 cost to the company ✔️ No hidden fees, no complicated terms—just straightforward savings ✔️ Easy implementation with full support from the Previ team Through this partnership, Aurobindo USA is taking a proactive step in enhancing their employees’ financial wellness without any extra cost. 💼🙌 We can’t wait to see the impact of these savings for their teams! 💪 Stay tuned for more updates as we continue to help companies bring financial benefits that really make a difference.

Biotechs making their commercial debut can improve their launch success rate and overall financial performance by learning from successful first-time launchers.

Biotechs making their commercial debut can improve their launch success rate and overall financial performance by learning from successful first-time launchers.

Biotechs making their commercial debut can improve their launch success rate and overall financial performance by learning from successful first-time launchers.

Biotechs making their commercial debut can improve their launch success rate and overall financial performance by learning from successful first-time launchers.